Attached files
| file | filename |
|---|---|
| EX-32.2 - Yubo International Biotech Ltd | e617589_ex32-2.htm |
| EX-31.2 - Yubo International Biotech Ltd | e617589_ex31-2.htm |
| EX-31.1 - Yubo International Biotech Ltd | e617589_ex31-1.htm |
| EX-10.63 - Yubo International Biotech Ltd | e617589_ex10-63.htm |
| EX-10.62 - Yubo International Biotech Ltd | e617589_ex10-62.htm |
| EX-10.61 - Yubo International Biotech Ltd | e617589_ex10-61.htm |
| 10-Q - Yubo International Biotech Ltd | e617589_10q-magna.htm |
EXHIBIT 32.1: CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
In connection with the accompanying Quarterly report on Form 10-Q of Magna-Lab, Inc. for the quarter ended November 30, 2017, the undersigned hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, to the best of my knowledge and belief, that:
| (1) | such Quarterly report on Form 10-Q for the quarter ended November 30, 2017 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and |
| (2) | the information contained in such Quarterly report on Form 10-Q for the quarter ended November 30, 2017 fairly presents, in all material respects, the financial condition and results of operations of Magna-Lab, Inc. |
| January 16, 2018 | /s/ Lawrence A. Minkoff | |||
| Name: Lawrence A. Minkoff | ||||
| Title: President (principal executive officer) |